Jianhua Li

Title: Innovations of Jianhua Li in Pharmaceutical Development

Introduction

Jianhua Li is a prominent inventor based in Sunnyvale, CA, known for his significant contributions to the field of pharmaceuticals. With a total of 11 patents to his name, he has made remarkable strides in developing treatments for various diseases, particularly those affecting neurological functions.

Latest Patents

Among his latest patents are innovative formulations related to Levodopa, a medication commonly used to treat Parkinson's disease. His patent titled "Levodopa prodrug mesylate, compositions thereof, and uses thereof" focuses on a specific compound, (2R)-2-Phenylcarbonyloxypropyl (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate mesylate, and its crystalline form. This patent outlines methods for creating the compound, pharmaceutical compositions, and applications for treating diseases such as Parkinson's disease. Another notable patent, "Levodopa prodrugs, and compositions and uses thereof," details the methods of making and using prodrugs of levodopa, showcasing his commitment to advancing therapeutic options in this area.

Career Highlights

Jianhua Li is currently associated with Xenoport, Inc., where he continues to innovate and develop new pharmaceutical solutions. His work has not only contributed to the scientific community but has also had a profound impact on patient care and treatment methodologies.

Collaborations

Throughout his career, Jianhua has collaborated with talented individuals such as Jia-Ning Xiang and Cindy X Zhou. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Jianhua Li's contributions to pharmaceutical innovations, particularly in the realm of neurological treatments, underscore his role as a leading inventor in the industry. His ongoing work promises to bring forth new solutions for patients suffering from debilitating conditions.